Skip to main content
Clinical Trials/CTRI/2020/09/028046
CTRI/2020/09/028046
Other
未知

Homoeopathy as an adjuvant to standard treatment protocol in management of corona virus infection- a randomised, placebo controlled, open label study.

Central Council for Research in Homeopathy Ministry Ministry of Ayush0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J708- Respiratory conditions due to other specified external agents
Sponsor
Central Council for Research in Homeopathy Ministry Ministry of Ayush
Status
Other
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Homeopathy Ministry Ministry of Ayush

Eligibility Criteria

Inclusion Criteria

  • Patients with corona virus infection reporting at Hospital, with all the following shall be included:
  • 1\.Laboratory confirmed cases of Corona virus infection.
  • 2\.Age 18 years to 80 years and both gender
  • 3\.Willing to give signed written informed consent

Exclusion Criteria

  • 1\.Patients on ventilatory support
  • 2\.Immunocompromised patients
  • 3\.Severe heart, lung, kidney, brain, blood diseases or other important systemic diseases
  • 4\.Subjects considered to be unable to complete the study, or not suitable for the study by researchers.
  • 5\.Women during pregnancy;

Outcomes

Primary Outcomes

Not specified

Similar Trials